肺がん:現在の治療法と新しい標的治療法
Fred R Hirsch1, Giorgio V Scagliotti2, James L Mulshine3
1Department of Medicine, Division of Medical Oncology and Department of Pathology, University of Colorado Cancer Center, Denver, CO, USA; International Association for the Study of Lung Cancer, Aurora, CO, USA.
Lancet (London, England)
|August 31, 2016
まとめ
このセミナーでは,現在の肺がん治療法と 精密医療について説明します.
科学分野:
- 腫瘍学
- 肺科
- 遺伝学
背景:
- 肺がんは世界中で がんによる死亡の主な原因で 毎年180万人が診断され160万人が死亡しています
- 肺がんの生存率は5年以内に4~17%で,疾患の段階や地域によって異なります.
研究 の 目的:
- 肺がんの治療法について
- 精密医療と新しい標的治療の可能性を 探求すること
- 肺がんを早期発見するためのスクリーニングを強調します
主な方法:
- 既存の肺がん治療のレビュー
- 精密医療のアプローチと標的治療の議論
- 肺がんのスクリーニング戦略の分析
主要な成果:
- 精密医療と標的治療は 肺がん治療の有望な進歩をもたらします
- 肺がんのスクリーニングは早期発見と改善のために不可欠です.
- 高齢者や機能不良の患者などの特定のサブグループには,個別の治療が必要である.
結論:
- 精密医療の進歩によって 肺がんの治療が変わりつつあります
- スクリーニングによる早期発見は 患者の生存に大きく影響を与えます
- すべての患者のサブグループに特化した治療枠組みについてはさらなる研究が必要である.
さらに関連する動画
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
11.1K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.8K
関連する概念動画
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies
1.7K
1.7K
Cancer Therapies
2.9K
2.9K
Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
